StockData
CDT Equity Inc. logo

CDT Equity Inc. (CDT) stock

CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 5/30
$0.44−0.07 (-13.10%)

Close on Nov 12, 2026Market cap $348.65KP/E –Yield –

Earnings

CDT Equity's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of CDT Equity's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

CDT Equity has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When CDT Equity puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases CDT Equity filed with the SEC as exhibits to Form 8-K or 6-K

  1. Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
    Update
  2. Equity Inc. Announces Reverse Stock Split
    Update
  3. Equity Inc. Announces Reverse Stock Split
    Update
  4. Equity Announces Debt Update and New Loan Facility
    News
  5. Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
    Update
  6. Equity Inc. Announces Reverse Stock Split
    Update
  7. Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
    Update
  8. Equity Inc. Announces Reverse Stock Split
    Update
  9. to Change Name to CDT Equity Inc.
    Update
  10. Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
    Update
  11. Pharmaceuticals Inc. Announces Reverse Stock Split
    Update
  12. 8-K exhibit EX-99.1
    Update
  13. Pharmaceuticals Inc. Announces Reverse Stock Split
    Update
  14. Conduit Pharmaceuticals to Revolutionize Drug
    Update
  15. DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF CONDUIT PHARMACEUTICALS LIMITED
    Update

See a number that looks wrong?